Literature DB >> 7901937

Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process.

M de L Higuchi1, P S Gutierrez, V D Aiello, S Palomino, E Bocchi, J Kalil, G Bellotti, F Pileggi.   

Abstract

Cellular subpopulations that infiltrate the heart in human chronic chagasic myocarditis were defined immunohistochemically in endomyocardial biopsy (EMB) specimens. T cells formed 96.3% of the inflammatory infiltrate, predominantly CD8+ (cytotoxic/suppressor) T cells. The mean numbers of CD8+ and CD4+ (helper) T cells in the myocarditis were compared to those present in the myocardial rejection process. Mean numbers of CD8+ T cells were similar in both groups of EMB specimens while CD4+ T cell counts, CD4+/CD8+ ratios and CD4+ antigen expression were significantly lower in the chagasic group compared to the myocardial rejection group (P < 0.002). The persistent lower number and diminished expression of CD4+ T cells suggest an immunological imbalance in patients with chronic chagasic myocarditis. A possible participation of Trypanosoma cruzi parasites in the development of such immunological abnormalities is also discussed.

Entities:  

Mesh:

Year:  1993        PMID: 7901937     DOI: 10.1007/bf01614765

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  20 in total

Review 1.  Pathophysiological insights into the cardiomyopathy of Chagas' disease.

Authors:  S A Morris; H B Tanowitz; M Wittner; J P Bilezikian
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

2.  Suppression of cellular responses in mice during Trypanosoma cruzi infections.

Authors:  E C Rowland; R E Kuhn
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

3.  Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings.

Authors:  M de L Higuchi; T De Brito; M Martins Reis; A Barbosa; G Bellotti; A C Pereira-Barreto; F Pileggi
Journal:  Cardiovasc Pathol       Date:  1993 Apr-Jun       Impact factor: 2.185

4.  Decreased human IL-2 receptor expression due to a protozoan pathogen.

Authors:  F Kierszenbaum; M B Sztein; L A Beltz
Journal:  Immunol Today       Date:  1989-04

5.  Right ventricular endomyocardial biopsy in chronic Chagas' disease.

Authors:  A C Pereira Barretto; C Mady; E Arteaga-Fernandez; N Stolf; E A Lopes; M L Higuchi; G Bellotti; F Pileggi
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

6.  Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.

Authors:  M B Sztein; W R Cuna; F Kierszenbaum
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

7.  The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies.

Authors:  M L Higuchi; C F De Morais; A C Pereira Barreto; E A Lopes; N Stolf; G Bellotti; F Pileggi
Journal:  Clin Cardiol       Date:  1987-11       Impact factor: 2.882

8.  Heterologous antibody responses in mice with chronic T. cruzi infection: depressed T helper function restored with supernatants containing interleukin 2.

Authors:  S G Reed; J A Inverso; S B Roters
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

9.  In situ analysis with monoclonal antibodies of lymphocyte subsets in myocardial biopsies from patients with dilated cardiomyopathy and idiopathic (viral) myocarditis.

Authors:  H Deguchi; T Hayashi; M Kotaka; Y Nakayama; Y Kitaura; K Kawamura
Journal:  Jpn Circ J       Date:  1987-12

10.  Association of elevated anti-sarcolemma, anti-idiotype antibody levels with the clinical and pathologic expression of chronic Chagas myocarditis.

Authors:  M Sadigursky; B F von Kreuter; P Y Ling; C A Santos-Buch
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

View more
  40 in total

Review 1.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Variability of kinetoplast DNA gene signatures of Trypanosoma cruzi II strains from patients with different clinical forms of Chagas' disease in Brazil.

Authors:  Eliane Lages-Silva; Luis Eduardo Ramírez; André Luiz Pedrosa; Eduardo Crema; Lúcia Maria da Cunha Galvão; Sérgio Danilo Junho Pena; Andrea Mara Macedo; Egler Chiari
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 3.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

4.  Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.

Authors:  B Wizel; N Garg; R L Tarleton
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

5.  Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents.

Authors:  I C Almeida; M M Camargo; D O Procópio; L S Silva; A Mehlert; L R Travassos; R T Gazzinelli; M A Ferguson
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

6.  Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.

Authors:  E Cunha-Neto; V Coelho; L Guilherme; A Fiorelli; N Stolf; J Kalil
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

7.  Immunopathologic characterization of naturally acquired Trypanosoma cruzi infection and cardiac sequalae in cynomolgus macaques (Macaca fascicularis).

Authors:  Harshan Pisharath; Chih-Ling Zao; John Kreeger; Susan Portugal; Thomas Kawabe; Tarea Burton; Lisa Tomaeck; Ahmed Shoieb; Brandy Morenko Campbell; Judy Franco
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

8.  Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.

Authors:  B Wizel; M Palmieri; C Mendoza; B Arana; J Sidney; A Sette; R Tarleton
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

9.  Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.

Authors:  Paulo E A Souza; Manoel O C Rocha; Cristiane A S Menezes; Janete S Coelho; Andréa C L Chaves; Kenneth J Gollob; Walderez O Dutra
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

10.  Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Susana A Laucella; María Gabriela Alvarez; Esteban Rodrigo Fernandez; Bruno Lococo; Rodolfo Viotti; Rick L Tarleton; Miriam Postan
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.